Short Call on Capricorn Therapeutics (CAPR)
about 2 months ago
"okay, so cash per share at Capricorn is 269. It's a good short. Make a little money. 50%ish. Maybe it'll go down to 214 and they have uh data coming out relatively soon here. Probably about two weeks. I like this guy."
An explicit trade call recommending a short position on Capricorn Therapeutics (CAPR) based on its current cash per share valuation and an anticipated data release in about two weeks.
Scores
Alpha Potential
8.0/10
Novelty
7.0/10
Credibility
8.0/10
Timeliness
9.0/10
Overall
8.0/10
Sentiment
Bearish
Conviction
High
Tier
Trade Call
Related Stocks
Episode Information
Episode:
Intellia: It's Not Looking Good. CAPR Short Around the Corner, Summit Stock Analysis |Martin Shkreli
Source:
The Shkreli Pill
Published:
October 28, 2025
Idea Type:
Stock Idea